NCT07739433

Brief Summary

Children with severe-to-profound congenital hearing loss often experience significant language development challenges. While cochlear implants (CIs) can restore auditory input, outcomes vary widely, even among those who receive implants early (before age 2) and undergo consistent speech therapy. This study aims to identify neural mechanisms underlying these differences.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
24mo left

Started Sep 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 31, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

July 31, 2026

Status Verified

July 1, 2026

Enrollment Period

1 year

First QC Date

July 28, 2026

Last Update Submit

July 28, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • The beta coefficient of theta-gamma phase-amplitude coupling (PAC) in the linear mixed-effect model

    language composite score is the dependent variable

    at enrollment

Secondary Outcomes (4)

  • Power-spectrum density (PSD) of the EEG resting-state oscillations

    at enrollment

  • peak frequencies of the EEG resting-state oscillations

    at enrollment

  • Multivariate temporal response functions (mTRF) in audiovisual and audio conditions

    at enrollment

  • Comparison of the 40Hz Auditory steady-state responses (ASSR) between participants with or without GJB2 variant

    at enrollment

Eligibility Criteria

Age4 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

This study will involve minors (between 4 and 17 years-old) with congenital severe-to-profound hearing loss with early bilateral CIs from pediatric ENT department of Necker hospital in Paris.

You may qualify if:

  • Age of first implantation less than or equal to 30 months
  • Bilateral CIs
  • Received CIs simultaneously or sequentially (the interval between two implantations does not exceed 18 months)
  • Congenital severe-to-profound hearing loss (PTA ≥90 dB HL)

You may not qualify if:

  • Children with severe associated disabilities who are assessed as unable to complete the tasks
  • Patients who, in the medical opinion of the Investigator, are unlikely to comply with the study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2026

First Posted

July 31, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2028

Last Updated

July 31, 2026

Record last verified: 2026-07